Julie Andrews Sells 712 Shares of Wright Medical Group NV (NASDAQ:WMGI) Stock

Share on StockTwits

Wright Medical Group NV (NASDAQ:WMGI) VP Julie Andrews sold 712 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $21.03, for a total transaction of $14,973.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Julie Andrews also recently made the following trade(s):

  • On Monday, June 3rd, Julie Andrews sold 1,447 shares of Wright Medical Group stock. The stock was sold at an average price of $30.65, for a total transaction of $44,350.55.

Shares of Wright Medical Group stock opened at $22.28 on Thursday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.91 and a quick ratio of 0.68. The firm has a fifty day moving average price of $25.76 and a 200 day moving average price of $29.52. Wright Medical Group NV has a 1 year low of $20.46 and a 1 year high of $32.86. The stock has a market cap of $2.74 billion, a PE ratio of 240.33, a price-to-earnings-growth ratio of 8.89 and a beta of 0.69.

Wright Medical Group (NASDAQ:WMGI) last issued its earnings results on Wednesday, August 7th. The medical device company reported $0.02 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.01 by $0.01. Wright Medical Group had a negative net margin of 14.65% and a positive return on equity of 1.38%. The firm had revenue of $229.73 million during the quarter, compared to analysts’ expectations of $233.04 million. During the same quarter last year, the company posted ($0.03) earnings per share. The firm’s revenue was up 11.8% compared to the same quarter last year. As a group, equities analysts expect that Wright Medical Group NV will post 0.16 EPS for the current year.

A number of research analysts have issued reports on WMGI shares. Royal Bank of Canada cut shares of Wright Medical Group from an “outperform” rating to a “sector perform” rating and decreased their price target for the stock from $34.00 to $24.00 in a report on Thursday, August 8th. Needham & Company LLC reaffirmed a “buy” rating and issued a $33.00 price target (down previously from $38.00) on shares of Wright Medical Group in a report on Tuesday, July 23rd. BidaskClub raised shares of Wright Medical Group from a “sell” rating to a “hold” rating in a report on Thursday, August 1st. Credit Suisse Group decreased their price target on shares of Wright Medical Group from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Thursday, August 8th. Finally, Piper Jaffray Companies set a $27.00 price target on shares of Wright Medical Group and gave the stock a “buy” rating in a report on Friday, August 16th. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $30.50.

Institutional investors have recently modified their holdings of the stock. Legal & General Group Plc raised its stake in Wright Medical Group by 6.4% during the 4th quarter. Legal & General Group Plc now owns 49,172 shares of the medical device company’s stock worth $1,339,000 after buying an additional 2,966 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Wright Medical Group by 54.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 885,249 shares of the medical device company’s stock worth $24,095,000 after purchasing an additional 312,947 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Wright Medical Group by 7.9% in the fourth quarter. Geode Capital Management LLC now owns 1,323,373 shares of the medical device company’s stock worth $36,022,000 after purchasing an additional 96,357 shares during the last quarter. Mercer Global Advisors Inc. ADV purchased a new stake in shares of Wright Medical Group in the first quarter worth approximately $267,000. Finally, Strs Ohio raised its stake in shares of Wright Medical Group by 5.4% in the first quarter. Strs Ohio now owns 15,700 shares of the medical device company’s stock worth $493,000 after purchasing an additional 800 shares during the last quarter.

About Wright Medical Group

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.

Featured Article: What is an overbought condition?

Insider Buying and Selling by Quarter for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.